Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease

Summary

The purpose of the study is to evaluate the safety, tolerability, and immunogenicity of RSVpreF in children 5 to \<18 years of age at high risk for RSV disease, including those who are immunocompromised.

Timeline

Start

2026-09-28

Primary completion

2031-04-01

Completion

2031-04-01

Drugs

Indications